NEW YORK, NY--(Marketwired - Jul 31, 2014) - IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (
Dr. Steven Victor, CEO of IntelliCell BioSciences, states, "We at IntelliCell and the New York Institute for Regenerative Medicine are pleased that a major sports magazine like Sports Illustrated has opened the door to the success of cellular therapy and, in IntelliCell's case, Stromal Vascular Fraction Cells for the treatment of injuries of athletes. We believe this is the future of medicine and can save numerous athletes from having to undergo surgery, and even if they do have surgery, the cellular treatment post-surgery helps them heal faster and gets them back on the field much sooner."
As Dr. Andrews stated in the article, "Instead of taking a year, a year and a half in order to get well, maybe we can cut that down in half," Andrews says. "We have an old saying: 'You can't bargain with Mother Nature.' The biologics, the stem-cell therapy, is the revelation that may change that."
About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
- Health Care Industry
- Sports Injuries
- Health Care Industry
- Dr. James Andrews
- Sports Illustrated
- adipose tissue
- regenerative medicine
IntelliCell BioSciences, Inc.